This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mmv Medicines for Malaria Venture. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nijmegen, NL (2023)
- XW Nijmegen, NL (2023)
Company Filing History:
Years Active: 2023
Title: **Innovations by Koen Jakob Dechering in Antimalarial Compounds**
Introduction
Koen Jakob Dechering, an inventor based in Nijmegen, Netherlands, has made significant contributions to the field of pharmaceutical innovations with a focus on antimalarial compounds. With a total of two patents to his name, his work addresses critical health issues related to malaria treatment.
Latest Patents
Dechering's latest invention revolves around pantothenamide analogues, which have demonstrated remarkable antimalarial activity. These novel compounds serve as analogues of pantothenamides and possess low IC values against both the asexual blood stages and gametocytes of malaria parasites. A notable feature of these pantothenamide analogues is their low hepatic metabolism, making them particularly suitable for therapeutic and prophylactic treatments of protozoan infections in humans or animals. Furthermore, the invention includes pharmaceutical formulations containing these analogues, promoting their practical application in combatting malaria.
Career Highlights
Dechering's affiliation with Medicines for Malaria Venture highlights his dedication to addressing global health challenges. His innovative research is pivotal in developing effective treatments to combat malaria, a disease that affects millions worldwide.
Collaborations
Throughout his career, Koen Jakob Dechering has worked alongside esteemed colleagues, including Josephus Schalkwijk and Pedro Harold Han Hermkens. These collaborations strengthen his research efforts and broaden the impact of his innovations in the pharmaceutical industry.
Conclusion
Koen Jakob Dechering's work on pantothenamide analogues represents a significant advancement in the fight against malaria. His patents not only enhance our understanding of antimalarial compounds but also pave the way for new therapeutic options. With ongoing collaborations and a commitment to innovation, Dechering continues to contribute to the essential field of medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile